These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8352517

  • 1. [Efficacy and tolerance of imipenem/cilastatin in the adjuvant treatment of surgery for peritonitis in patients over the age of 70 years].
    Janvier G, Carles J.
    Ann Chir; 1993; 47(4):370-5. PubMed ID: 8352517
    [Abstract] [Full Text] [Related]

  • 2. [Study of the efficacy and tolerance of imipenem-cilastatin used as monotherapy for the adjuvant treatment to surgery of peritonitis. Results of a French multicenter study including 257 patients].
    Midy D, Pometan JP, Baste JC, Pajadon V.
    J Chir (Paris); 1992; 129(6-7):303-8. PubMed ID: 1474112
    [Abstract] [Full Text] [Related]

  • 3. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia.
    Bartoloni A, Strohmeyer M, Corti G, Buonomini MI, Franchino L, Romanelli G, Moretti AM, De Vizzi GB, Petraglia A, Mancini P, Atzeni R, Fogliani V, Giura R, Paradisi F.
    Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862
    [Abstract] [Full Text] [Related]

  • 4. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
    Cakmakci M, Stern A, Schilling J, Christen D, Roggo A, Geroulanos S.
    Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
    [Abstract] [Full Text] [Related]

  • 5. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients.
    Kuo BI, Fung CP, Liu CY.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Garbino J, Villiger P, Caviezel A, Matulionyte R, Uckay I, Morel P, Lew D.
    Infection; 2007 Jun; 35(3):161-6. PubMed ID: 17565457
    [Abstract] [Full Text] [Related]

  • 9. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H, Björkholm M, Engervall P, Johansson P, Ljungman P, Hast R, Kalin M.
    Scand J Infect Dis; 2004 Jun; 36(8):593-600. PubMed ID: 15370671
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: results of a multicenter study.
    Eckhauser FE, Knol JA, Raper SE, Mulholland MW, Helzerman P.
    Clin Ther; 1992 Jun; 14(1):97-109. PubMed ID: 1576632
    [Abstract] [Full Text] [Related]

  • 12. Piperacillin/tazobactam versus imipenem/cilastatin in the treatment of intra-abdominal infections.
    Niinikoski J, Havia T, Alhava E, Pääkkönen M, Miettinen P, Kivilaakso E, Haapiainen R, Matikainen M, Laitinen S.
    Surg Gynecol Obstet; 1993 Mar; 176(3):255-61. PubMed ID: 8382381
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Contribution of imipenem/cilastatin in the treatment of peritonitis: a comparative economic analysis in the case of France].
    Levy E, Levy P.
    J Chir (Paris); 1993 Apr; 130(4):200-9. PubMed ID: 8345014
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Imipenem versus netilmicin and vancomycin in the treatment of CAPD peritonitis.
    Merchant MR, Anwar N, Were A, Uttley L, Tooth JA, Gokal R.
    Adv Perit Dial; 1992 Apr; 8():234-7. PubMed ID: 1361795
    [Abstract] [Full Text] [Related]

  • 17. Impact an anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections.
    Wilson SE, Faulkner K.
    Am Surg; 1998 May; 64(5):402-7. PubMed ID: 9585772
    [Abstract] [Full Text] [Related]

  • 18. Meropenem (1.5 g/day) is as effective as imipenem/cilastatin (2 g/day) for the treatment of moderately severe intra-abdominal infections.
    Zanetti G, Harbarth SJ, Trampuz A, Ganeo M, Mosimann F, Chautemps R, Morel P, Lew D, Zimmerli W, Lange J, Glauser M.
    Int J Antimicrob Agents; 1999 Feb; 11(2):107-13. PubMed ID: 10221413
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.